Companies: 10,795·Total market cap: $144.5T
LifeMD, Inc.

LifeMD, Inc.

LFMDNASDAQHealthcare● Active
$4.90
+$0.01(+0.23%)
Market Cap$237029449
P/E Ratio
52W High$15.84
52W Low$2.56

LifeMD, Inc. (LFMD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

lfmd · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for LifeMD, Inc. (LFMD) measures how much investors pay for each dollar of the company's trailing earnings. LFMD's current PE ratio of N/A is calculated by dividing its stock price of $4.90 by its TTM earnings per share of -$0.34.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.27
Based on 3 analysts
EPS (TTM)
-$0.34
TTM · diluted EPS
PEG Ratio
0.13
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LifeMD, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2011 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Pharmaceuticals · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
LifeMD, Inc.
LifeMD, Inc.You
LFMD
$237MN/A-$0.34
Cerus Corporation
Cerus Corporation
CERS
$526MN/A-$0.08
CVRx, Inc.
CVRx, Inc.
CVRX
$144MN/A-$2.04
High Tide Inc.
High Tide Inc.
HITI
$205MN/A-$0.62
908 Devices Inc.
908 Devices Inc.
MASS
$308MN/A-$1.01
Owens & Minor, Inc.
Owens & Minor, Inc.
OMI
$207MN/A-$14.24
Senseonics Holdings, Inc.
Senseonics Holdings, Inc.
SENS
$296MN/A-$1.66

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 15 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.16
2024-12-31
FY2024
$-0.46
2023-12-31
FY2023
$-0.61
2022-12-31
FY2022
$-1.47
2021-12-31
FY2021
$-2.25
2020-12-31
FY2020
$-4.11
2019-12-31
FY2019
$-0.32
2018-12-31
FY2018
$-0.14
2017-12-31
FY2017
$-0.14
2016-12-31
FY2016
$-0.16

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for LifeMD, Inc. (LFMD) measures how much investors pay for each dollar of the company's trailing earnings. LFMD's current PE ratio of N/A is calculated by dividing its stock price of $4.90 by its TTM earnings per share of -$0.34.

PE Ratio = Stock Price ÷ EPS (TTM)
= $4.90 ÷ -$0.34 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

LFMD pe ratio · 6 questions

LFMD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $4.90 and TTM EPS of -$0.34. Data sourced from Financial Modeling Prep via LFMD's SEC 10-K and 10-Q filings.

LFMD PE ratioWhat is LFMD PE ratioCurrent PE ratio of LFMDLFMD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LifeMD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08